Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Emerging concepts in the science of vaccine adjuvantsNature reviews. Drug discovery, 2021-06, Vol.20 (6), p.454-475 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-021-00163-y ;PMID: 33824489Full text available |
|
2 |
Material Type: Article
|
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccineNature immunology, 2022-04, Vol.23 (4), p.543-555 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Nature America, Inc. ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2022. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-022-01163-9 ;PMID: 35288714Full text available |
|
3 |
Material Type: Article
|
A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in miceNature communications, 2022-01, Vol.13 (1), p.549-549, Article 549 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-28197-9 ;PMID: 35087093Full text available |
|
4 |
Material Type: Article
|
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesNature communications, 2023-04, Vol.14 (1), p.2149-2149, Article 2149 [Peer Reviewed Journal]2023. The Author(s). ;The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-37417-9 ;PMID: 37069151Full text available |
|
5 |
Material Type: Article
|
Durability of immune responses to mRNA booster vaccination against COVID-19The Journal of clinical investigation, 2023-05, Vol.133 (10), p.1-10 [Peer Reviewed Journal]COPYRIGHT 2023 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation May 2023 ;2023 Arunachalam et al. 2023 Arunachalam et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI167955 ;PMID: 36951954Full text available |
|
6 |
Material Type: Article
|
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infectionPLoS pathogens, 2021-02, Vol.17 (2), p.e1009257-e1009257 [Peer Reviewed Journal]2021 Charles et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Charles et al 2021 Charles et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/JOURNAL.PPAT.1009257 ;PMID: 33556148Full text available |
|
7 |
Material Type: Article
|
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesNature communications, 2023-10, Vol.14 (1), p.6211-6211, Article 6211 [Peer Reviewed Journal]The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Springer Nature Limited 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-42061-4 ;PMID: 37798288Full text available |
|
8 |
Material Type: Article
|
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in micenpj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518Full text available |
|
9 |
Material Type: Article
|
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics studyeLife, 2022-10, Vol.11 [Peer Reviewed Journal]2022, Hu et al. ;2022, Hu et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022, Hu et al 2022 Hu et al ;ISSN: 2050-084X ;EISSN: 2050-084X ;DOI: 10.7554/elife.77943 ;PMID: 36239699Full text available |
|
10 |
Material Type: Article
|
Immune responses to SARS-CoV-2 in the lungThorax, 2021-10, Vol.76 (10), p.961-961 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage ;ISSN: 0040-6376 ;EISSN: 1468-3296 ;DOI: 10.1136/thoraxjnl-2021-217231 ;PMID: 34088785Full text available |
|
11 |
Material Type: Article
|
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humansScience, 2020-09, Vol.369 (6508) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc6261Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Systems vaccinology of the BNT162b2 mRNA vaccine in humansNature (London), 2021-08, Vol.596 (7872), p.410-416 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Aug 19, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03791-x ;PMID: 34252919Full text available |
|
13 |
Material Type: Article
|
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationCell, 2022-03, Vol.185 (6), p.1025-1040.e14 [Peer Reviewed Journal]2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;2022 The Authors 2022 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.01.018 ;PMID: 35148837Full text available |
|
14 |
Material Type: Article
|
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesCell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077Full text available |
|
15 |
Material Type: Article
|
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titersNature medicine, 2020-06, Vol.26 (6), p.932-940 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-0858-8 ;PMID: 32393800Full text available |
|
16 |
Material Type: Article
|
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in MongoliaCell host & microbe, 2021-12, Vol.29 (12), p.1738-1743.e4 [Peer Reviewed Journal]2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;2021 The Authors 2021 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.11.004 ;PMID: 34861167Full text available |
|
17 |
Material Type: Article
|
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infectionImmunity (Cambridge, Mass.), 2023-04, Vol.56 (4), p.864-878.e4 [Peer Reviewed Journal]2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2023.03.005 ;PMID: 36996809Full text available |
|
18 |
Material Type: Article
|
PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype CThe Journal of biological chemistry, 2018-07, Vol.293 (30), p.11687-11708 [Peer Reviewed Journal]2018 ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.M117.815829 ;PMID: 29773649Full text available |
|
19 |
Material Type: Article
|
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primatesCellular & molecular immunology, 2022-02, Vol.19 (2), p.222-233 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1672-7681 ;EISSN: 2042-0226 ;DOI: 10.1038/s41423-021-00809-2 ;PMID: 34983950Full text available |
|
20 |
Material Type: Article
|
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and miceCell Reports, 2022-08, Vol.40 (9), p.111299-111299, Article 111299 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Author(s) 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.111299 ;PMID: 35988541Digital Resources/Online E-Resources |